These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome. van der Meer JW; Simon A Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii23-ii29. PubMed ID: 27856657 [TBL] [Abstract][Full Text] [Related]
24. Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics. Teitsma XM; Jacobs JWG; Concepcion AN; Pethö-Schramm A; Borm MEA; van Laar JM; Bijlsma JWJ; Lafeber FPJG Clin Exp Rheumatol; 2018; 36(6):976-983. PubMed ID: 29745885 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Ammouri W; Cuisset L; Rouaghe S; Rolland MO; Delpech M; Grateau G; Ravet N Rheumatology (Oxford); 2007 Oct; 46(10):1597-600. PubMed ID: 17804452 [TBL] [Abstract][Full Text] [Related]
26. Two cases of periodic fever syndrome with coexistent mevalonate kinase and Mediterranean fever gene mutations. Çakan M; Aktay-Ayaz N; Keskindemirci G; Karadağ ŞG Turk J Pediatr; 2017; 59(4):467-470. PubMed ID: 29624229 [TBL] [Abstract][Full Text] [Related]
27. Hyper-IgD syndrome or mevalonate kinase deficiency. Stoffels M; Simon A Curr Opin Rheumatol; 2011 Sep; 23(5):419-23. PubMed ID: 21760510 [TBL] [Abstract][Full Text] [Related]
28. STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation. Klampfer L; Huang J; Kaler P; Sasazuki T; Shirasawa S; Augenlicht L Oncogene; 2007 Mar; 26(14):2071-81. PubMed ID: 17016440 [TBL] [Abstract][Full Text] [Related]
29. Fevers, genes, and innate immunity. Ryan JG; Kastner DL Curr Top Microbiol Immunol; 2008; 321():169-84. PubMed ID: 18727492 [TBL] [Abstract][Full Text] [Related]
30. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases. Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606 [TBL] [Abstract][Full Text] [Related]
32. STAT1 expression and activation is increased in lesional psoriatic skin. Hald A; Andrés RM; Salskov-Iversen ML; Kjellerup RB; Iversen L; Johansen C Br J Dermatol; 2013 Feb; 168(2):302-10. PubMed ID: 23013371 [TBL] [Abstract][Full Text] [Related]
33. Severe phenotypic spectrum of mevalonate kinase deficiency with minimal mevalonic aciduria. Prasad C; Salvadori MI; Rupar CA Mol Genet Metab; 2012 Dec; 107(4):756-9. PubMed ID: 23146290 [TBL] [Abstract][Full Text] [Related]
34. Proteogenomics of Malignant Melanoma Cell Lines: The Effect of Stringency of Exome Data Filtering on Variant Peptide Identification in Shotgun Proteomics. Lobas AA; Pyatnitskiy MA; Chernobrovkin AL; Ilina IY; Karpov DS; Solovyeva EM; Kuznetsova KG; Ivanov MV; Lyssuk EY; Kliuchnikova AA; Voronko OE; Larin SS; Zubarev RA; Gorshkov MV; Moshkovskii SA J Proteome Res; 2018 May; 17(5):1801-1811. PubMed ID: 29619825 [TBL] [Abstract][Full Text] [Related]
35. STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ. He C; Medley SC; Kim J; Sun C; Kwon HR; Sakashita H; Pincu Y; Yao L; Eppard D; Dai B; Berry WL; Griffin TM; Olson LE Genes Dev; 2017 Aug; 31(16):1666-1678. PubMed ID: 28924035 [TBL] [Abstract][Full Text] [Related]
36. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome. Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279 [TBL] [Abstract][Full Text] [Related]
37. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668 [TBL] [Abstract][Full Text] [Related]